Malaria, Plasmodium falciparum, Kenya
Showing 1 - 25 of 1,646
Plasmodium Falciparum Infection, Malaria Trial in Kisumu (L9LS, Normal Saline)
Recruiting
- Plasmodium Falciparum Infection
- Malaria
- L9LS
- Normal Saline
-
Kisumu, KenyaKenya Medical Research Institute (KEMRI) Center for Global Healt
Sep 15, 2022
Plasmodium Falciparum Malaria Trial in Burkina Faso, Congo, The Democratic Republic of the, Mali (artemether:lumefantrine (2.5
Recruiting
- Plasmodium Falciparum Malaria
- artemether:lumefantrine (2.5 mg:30 mg)
-
Nanoro, Burkina Faso
- +5 more
Nov 28, 2022
Malaria,Falciparum Trial in Kilifi (PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine)
Not yet recruiting
- Malaria,Falciparum
- PfSPZ Challenge
- +4 more
-
Kilifi, KenyaKEMRI-Wellcome Trust Research Programme
May 17, 2022
Human Immunity to MSP-1 in Western Kenya
Completed
- Plasmodium Falciparum Malaria
-
Kisumu, KenyaKenya Medical Research Institute
Jan 5, 2022
LLIN, PBO LLIN, IRS, Larviciding Trial in Irvine, Homa Bay (Regular long-lasting insecticidal nets, LLIN plus Piperonyl
Recruiting
- LLIN, PBO LLIN, IRS, Larviciding
- Regular long-lasting insecticidal nets
- +3 more
-
Irvine, California
- +1 more
Feb 1, 2023
Plasmodium Falciparum Infection Trial in Worldwide (Ferroquine SSR97193, Artefenomel, Placebo)
Terminated
- Plasmodium Falciparum Infection
- Ferroquine SSR97193
- +2 more
-
Cotonou, Benin
- +11 more
Mar 15, 2022
Acute Uncomplicated Plasmodium Falciparum Malaria Trial in Worldwide (KAF156, Coartem, Lumefantrine Solid Dispersion
Completed
- Acute Uncomplicated Plasmodium Falciparum Malaria
- KAF156
- +2 more
-
Nanoro, Burkina Faso
- +10 more
Dec 21, 2021
Plasmodium Falciparum Infection Trial in Worldwide (Artefenomel (OZ439), Ferroquine (SSR97193))
Completed
- Plasmodium Falciparum Infection
- Artefenomel (OZ439)
- Ferroquine (SSR97193)
-
Cotonou, Benin
- +6 more
Mar 10, 2022
Malaria,Falciparum Trial (Artemether-lumefantrine (AL), Dihydroartemisinin-piperaquine (DP))
Completed
- Malaria,Falciparum
- Artemether-lumefantrine (AL)
- Dihydroartemisinin-piperaquine (DP)
- (no location specified)
Sep 27, 2021
Uncomplicated Malaria Trial in Bungoma, Siaya (artemether lumefantrine, dihydroartemisinin piperaquine)
Recruiting
- Uncomplicated Malaria
- artemether lumefantrine
- dihydroartemisinin piperaquine
-
Bungoma, Bungoma County, Kenya
- +1 more
Nov 15, 2021
Malaria Trial in Busia (Transfluthrin, Placebo)
Enrolling by invitation
- Malaria
- Transfluthrin
- Placebo
-
Busia, Busia County, Kenya
- +1 more
Nov 15, 2021
Plasmodium Falciparum Trial in Kilifi (Arterolane-piperaquine, Arterolane-piperaquine+mefloquine, Artemether-lumefantrine)
Completed
- Plasmodium Falciparum
- Arterolane-piperaquine
- +2 more
-
Kilifi, KenyaKilifi County Hospital
Sep 28, 2021
Plasmodium Falciparum Trial in Kisumu (RTS,S/AS01E, Abhayrab rabies vaccine)
Active, not recruiting
- Plasmodium Falciparum
- RTS,S/AS01E
- Abhayrab rabies vaccine
-
Kisumu, Kisumu County, KenyaKombewa Clinical Research Center
Oct 7, 2021
Malaria,Falciparum, Malaria, Vivax, Malaria Trial in Manokwari (Dihydroartemisinin, Piperaquine, Primaquine)
Completed
- Malaria,Falciparum
- +5 more
- Dihydroartemisinin
- +3 more
-
Manokwari, West Papua, IndonesiaManokwari Regional General Hospital
Sep 11, 2023
Malaria Trial in Worldwide (pyronaridine artesunate, arthemeter lumefantrine)
Completed
- Malaria
- pyronaridine artesunate
- arthemeter lumefantrine
-
Ouagadougou, Burkina Faso
- +7 more
Oct 22, 2021
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Malaria Trial (Plasmodium falciparum Malaria Protein 010 (FMP010), Rabipur)
Completed
- Malaria
- Plasmodium falciparum Malaria Protein 010 (FMP010)
- Rabipur
- (no location specified)
Feb 10, 2021
Malaria Trial (Meplazumab for Injection)
Not yet recruiting
- Malaria
- Meplazumab for Injection
- (no location specified)
Sep 13, 2023
Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria Trial (ZY19489 + Ferroquine (FQ), Placebo)
Not yet recruiting
- Uncomplicated Malaria
- +2 more
- ZY19489 + Ferroquine (FQ)
- Placebo
- (no location specified)
Jun 18, 2023
Malaria, Plasmodium Falciparum Trial in Oxford (Pfs48/45 in Matrix-M)
Recruiting
- Malaria
- Plasmodium Falciparum
- Pfs48/45 in Matrix-M
-
Oxford, United KingdomCCVTM, University of Oxford
Dec 13, 2022
TES of Artemether-lumefantrine for Pf in Philippines in
Completed
- Malaria,Falciparum
- Malaria Recrudescence
- (no location specified)
Jul 20, 2023
Malaria,Falciparum Trial (Artemisia afra or Annua 10g oral infusion/tea per day for 14 days)
Not yet recruiting
- Malaria,Falciparum
- Artemisia afra or Annua 10g oral infusion/tea per day for 14 days
- (no location specified)
Mar 23, 2023
TES of Artemether-lumefantrine for Pf in the Philippines in 2015
Completed
- Malaria,Falciparum
- Malaria Recrudescence
- (no location specified)
Jul 20, 2023
Plasmodium Falciparum Trial in Kisumu (RTS, S/AS01B, RTS, S/AS02A, Rabipur (Rabies) Vaccine)
Completed
- Plasmodium Falciparum
- RTS, S/AS01B
- +2 more
-
Kisumu, KenyaU.S. Army Research Unit-Kenya
Feb 10, 2021
Malaria,Falciparum Trial in Kilifi (R21/Matrix-M, ChAd63/MVA ME-TRAP, intradermal injection (ID) or direct venous injection
Recruiting
- Malaria,Falciparum
- R21/Matrix-M
- +2 more
-
Kilifi, KenyaKEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R
Sep 14, 2022